To evaluate the relationships between the serum concentration of EGFR-TKIs and the effects and toxicities of them

To evaluate the relationships between the serum concentration of EGFR-TKIs and the effects and toxicities of them - To evaluate the serum concentration of EGFR-TKIs

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001066

Enrollment

Registered

2013-12-31

Start date

2007-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NSCLC

Interventions

EGFR-TKIs

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: advanced NSCLC EGFR-TKI treatment case

Exclusion criteria

Exclusion criteria: Interstitial pnumonaitis

Design outcomes

Primary

Measure	Time frame
PFS	—

Secondary

Measure	Time frame
Adverse events OP	—

Countries

Japan

Contacts

Public ContactNakamura Yoichi

Nagasaki University School of Medicine Second Department of Internal Medicine

yi-nakamu@umin.ac.jp095-819-7273

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026